About Technology Issues FAQ

Links

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.